Our Partners
CONTINUUS
Expertise Partner
CONTINUUS Pharmaceuticals is leveraging a novel state-of-the-art pharmaceutical
manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through a Novartis-MIT research collaboration. ICM represents the most advanced method for producing small molecule drugs and enables the
entire manufacturing process, from starting materials to the final product, to be placed in a single seamless production line. This is
a fundamentally different from batch manufacturing, and offers considerable advantages in costefficiency, lead time, production flexibility, quality assurance, and environmental impact. Learn more about CONTINUUS and ICM.